ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 30 filers reported holding ZOSANO PHARMA CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $45,000 | -52.1% | 199,497 | 0.0% | 0.00% | – |
Q4 2021 | $94,000 | -34.7% | 199,497 | 0.0% | 0.00% | – |
Q3 2021 | $144,000 | -24.2% | 199,497 | 0.0% | 0.00% | – |
Q2 2021 | $190,000 | -23.1% | 199,497 | 0.0% | 0.00% | – |
Q1 2021 | $247,000 | +263.2% | 199,497 | +53.5% | 0.00% | – |
Q4 2020 | $68,000 | -64.8% | 129,940 | +9.3% | 0.00% | – |
Q3 2020 | $193,000 | +124.4% | 118,881 | +17.9% | 0.00% | – |
Q2 2020 | $86,000 | +196.6% | 100,814 | +93.0% | 0.00% | – |
Q1 2020 | $29,000 | +16.0% | 52,238 | +221.4% | 0.00% | – |
Q4 2019 | $25,000 | 0.0% | 16,252 | 0.0% | 0.00% | – |
Q3 2019 | $25,000 | -52.8% | 16,252 | 0.0% | 0.00% | – |
Q2 2019 | $53,000 | -32.1% | 16,252 | 0.0% | 0.00% | – |
Q1 2019 | $78,000 | +32.2% | 16,252 | -41.7% | 0.00% | – |
Q4 2018 | $59,000 | -48.2% | 27,891 | 0.0% | 0.00% | – |
Q3 2018 | $114,000 | -4.2% | 27,891 | -4.3% | 0.00% | – |
Q2 2018 | $119,000 | – | 29,138 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,600,000 | $7,632,000 | 5.81% |
Telemetry Investments, L.L.C. | 242,826 | $1,158,000 | 0.59% |
MYDA Advisors LLC | 72,000 | $343,000 | 0.17% |
Highlander Capital Management, LLC | 10,000 | $48,000 | 0.03% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $4,770,000 | 0.01% |
Hartford Financial Management Inc. | 2,000 | $10,000 | 0.00% |
GABELLI FUNDS LLC | 21,297 | $102,000 | 0.00% |
IFP Advisors, Inc | 1,248 | $6,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 81,829 | $390,000 | 0.00% |
DEUTSCHE BANK AG\ | 100 | $0 | 0.00% |